Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

20061,189 citationsJournal Articlebronze Open Access

Authors

Lon S. Schneider · University of Southern California

Pierre N. Tariot · Banner Alzheimer’s Institute

Karen Dagerman · University of Southern California

Sonia M. Davis · IQVIA (United States)

John Hsiao · National Institute of Mental Health

M. Saleem Ismail · University of Rochester Medical Center

Barry D. Lebowitz

Abstract

Adverse effects offset advantages in the efficacy of atypical antipsychotic drugs for the treatment of psychosis, aggression, or agitation in patients with Alzheimer's disease. (ClinicalTrials.gov number, NCT00015548 [ClinicalTrials.gov].).

Topics & Keywords

Schizophrenia research and treatment Dementia and Cognitive Impairment Research Mental Health and Psychiatry

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 355, Issue 15, pp. 1525-1538

DOI: 10.1056/nejmoa061240

Field-Weighted Citation Impact: 53.77